Download PDFPDF

708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address